Cargando…
An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases
The protozoan diseases Human African Trypanosomiasis (HAT), Chagas disease (CD), and leishmaniases span worldwide and therefore their impact is a universal concern. The present regimen against kinetoplastid protozoan infections is poor and insufficient. Target-based design expands the horizon of dru...
Autores principales: | Kourbeli, Violeta, Chontzopoulou, Eleni, Moschovou, Kalliopi, Pavlos, Dimitrios, Mavromoustakos, Thomas, Papanastasiou, Ioannis P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348971/ https://www.ncbi.nlm.nih.gov/pubmed/34361781 http://dx.doi.org/10.3390/molecules26154629 |
Ejemplares similares
-
Exploring the Binding Effects of Natural Products and Antihypertensive Drugs on SARS-CoV-2: An In Silico Investigation of Main Protease and Spike Protein
por: Moschovou, Kalliopi, et al.
Publicado: (2023) -
Discovery and Characterization
of Clinical Candidate
LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment
of Leishmaniases
por: Nagle, Advait, et al.
Publicado: (2020) -
Target Identification and Intervention Strategies against Kinetoplastid Protozoan Parasites
por: Majumder, Hemanta K., et al.
Publicado: (2011) -
Human Kinetoplastid Protozoan Infections: Where Are We Going Next?
por: Filardy, Alessandra Almeida, et al.
Publicado: (2018) -
A Critical Overview of Interleukin 32 in Leishmaniases
por: Ribeiro-Dias, Fátima, et al.
Publicado: (2022)